The Innovative Medicines Initiative has now launched IMI2 – Call 21 on the development of therapeutics and diagnostics combatting coronavirus infections.
IMI2 – Call 21 on the development of therapeutics and diagnostics combatting coronavirus infections is a single stage Call for proposals. Please note that preventive vaccines are specifically excluded from the scope of the Call.
Deadline for short proposals: 31 March 2020
Call web page
All topic texts, Call documentation and details of how to apply can be found on the IMI website.
IMI will hold a webinar on IMI2 – Call 21 on Wednesday 4 March at 14:30. Registration for the webinar is now closed, as the webinar is full. However, the webinar will be recorded, and the recording and slides will be published on the IMI website after the webinar. In addition, applicants who wish to be part of the webinar participant list for networking purposes should follow the instructions on the webinar page.
The IMI website includes pages with advice for applicants and guidance on how to find project partners.